Navigating Your Clinical Trial with Precision and Speed
Point-of-Care (POC) diagnostic trials for influenza are unlike any other. The season is short, virus circulation is unpredictable, and enrollment targets — particularly for influenza B — are notoriously difficult to meet. Every week counts, and missteps in site startup, patient access, or data flow can jeopardize an entire program.
At Beaufort, we’ve built our approach to meet these challenges head-on. We deliver end-to-end CRO services with proven expertise and proactive strategies that simplify complexity and safeguard timelines. Our team integrates rapid site activation, flexible patient recruitment, streamlined vendor oversight, real-time data management, and inspection-ready quality systems — ensuring sponsors capture the season and achieve submission-ready results.
Strategic & Targeted Patient Access
Meeting enrollment targets in an influenza in vitro diagnostic (IVD) trial requires a precise understanding of seasonal influenza patterns and a proactive, flexible approach to sample collection. Beaufort applies strategies that enable rapid site activation and maximize subject participation during peak influenza circulation through:
Enrollment success depends on activating the right sites at the right time — and that’s where Beaufort excels.
- Development of a seasonally aligned, high-throughput, and geographically diverse enrollment plan supported by real-time monitoring of influenza positivity rates and contingency strategies to ensure sufficient influenza B cases.
- Definition of clear inclusion criteria based on influenza-like illness (ILI) symptoms and prioritization of high-volume, high-performing sites such as urgent care centers, outpatient clinics, and pediatric practices to accelerate trial startup.
- Application of flexible and nimble enrollment processes enabling sites to rapidly identify, consent, and collect samples from eligible patients, ensuring timely completion of enrollment within the influenza season.
Streamlined Trial Operations & Delivery
The seasonality of influenza, coupled with complex logistics and vendor coordination, demands efficiency and adaptability. Beaufort structures its delivery model to keep specimen flow uninterrupted, vendors aligned, and monitoring optimized throughout the influenza season by:
- Deploying a full and experienced trial team at launch to ensure rapid scale-up ahead of peak influenza circulation.
- Harmonizing vendor and laboratory oversight with a dedicated manager streamlining contracting, specimen handling, and testing logistics.
- Optimizing clinical monitoring and site oversight for timely verification of enrollment data, sample integrity, and rapid issue resolution.
- Building a streamlined data management framework with standardized processes, real-time data reconciliation, and rapid cleaning of laboratory and clinical data streams.
Continuous specimen flow is the difference between meeting timelines and missing the season.
Together, these measures shorten startup timelines, maintain uninterrupted specimen flow, reduce operational bottlenecks, and accelerate data readiness — all essential to executing influenza IVD trials within the narrow seasonal window.
Relentless Quality Assurance from Day One
Quality and compliance are safeguarded from the very beginning. Beaufort implements measures that protect data integrity, ensure inspection readiness, and keep the trial financially on track at every stage:
- An inspection readiness program is launched from the start.
- Data quality standards are implemented across clinical monitoring and data reviews.
- Customized visual dashboards are designed to track site progress, compliance, and key milestones.
- Financial project analysis is conducted to detect, report, and mitigate potential budget variances.
These quality assurance measures reduce operational risk, minimize data cleaning burdens, prevent compliance setbacks, and keep the trial financially stable — increasing both efficiency and confidence in delivering influenza IVD trials within seasonal timelines.
Results that Meet Your Needs
Beaufort’s integrated approach to patient access, streamlined delivery, and relentless quality assurance ensures the successful execution of influenza IVD trials in seasonal respiratory infection:
- Enrollment targets are met on schedule, with a seasonally aligned and geographically diverse plan.
- Rapid site activation and flexible recruitment processes accelerate enrollment, ensuring timely completion within the influenza season.
- Real-time monitoring and proactive data management accelerate interim analysis delivery and maintain continuous visibility of site performance.
- Inspection readiness and compliance programs safeguard regulatory preparedness, while standardized quality measures reduce the incidence of data queries and increase protocol compliance rates.
- Proactive financial oversight keeps the trial on track, with early analysis mitigating potential budget variances.
Seasonal Trials Move Fast. So Do We.
This integrated CRO services model reduces delays, prevents bottlenecks, and accelerates both enrollment and data readiness, ensuring influenza IVD trials are completed efficiently within the narrow seasonal timeframe.
👉 Let’s talk about how Beaufort’s CRO services can accelerate your influenza program and deliver results on time. Contact Us Today.